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ABSTRACT 
Autism Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD) are 
complex neurodevelopmental disorders (NDD), heterogeneous in phenotypes and etiology. 
The exact mechanisms driving the phenotypes are still largely unknown. The overall aim of 
this thesis is to find new leads for ASD and ADHD etiology, focusing on environmental 
factors through the examination of discordant twins. For this purpose, two ASD enriched and 
well characterized twin cohorts were investigated; the Roots of Autism and ADHD Twin 
Study of Sweden (RATSS) and the Californian Autism Twin Study (CATS). In study I, we 
are discussing the background the aims and the rationale for the RATSS program.  
In study II, the association between ASD and IQ is examined. There is a robust and negative 
phenotypic correlation between IQ and ASD, categorical as well as dimensional, underpinned 
by genetic and non-shared environmental (NSE) factors. The role of non-shared environment 
in ASD, focusing on early medical events, is explored in Study III. There is an association 
between the total load of early medical events and ASD, both categorically as well as 
dimensionally defined. The association is particularly driven by behavioral dysregulation in 
infants (feeding and sleeping problems, excessive crying and worriedness) as a function of 
NSE factors. In study IV, we test the hypothesis of a link between ASD and pre- and 
postnatal dysregulation of metals. ASD cases demonstrate higher lead levels during a period 
of 20 weeks before and 30 weeks after birth, lower manganese levels 17 weeks prenatally to 
30 weeks postnatally, and a reduction in zinc 10 weeks prenatally to five weeks postnatally.  
In study V we study executive functioning as a behavioral marker of ADHD. There is a link 
between ADHD on one hand, and foresighted planning and inhibitory control on the other 
hand, mediated by NSE factors.  
In summary, the findings support ASD to be continuously distributed in the population with 
clinical phenotypes being the extremes of these continuums. They point to a cumulative 
multifactor threshold model, including both genetic and NSE components in the etiology of 
ASD. More specifically, the results support that systemic pre- and postnatal elemental 
dysregulation increase ASD risk, and an association between early medical events and ASD 
risk. The findings also indicate low IQ to be a behavioral marker for ASD, and poor 
executive functioning to be a behavioral marker for ADHD. Both these association are 
underpinned by NSE factors.  
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1 INTRODUCTION 
1.1 NEURODEVELOPMENTAL DISORDERS 
1.1.1 Symptomatology, Prevalence and Comorbidity  
1.1.1.1 Neurodevelopmental Disorders  
Neurodevelopmental disorders (NDDs) are defined by early and persistent developmental 
behavior difficulties leading to functional impairments in everyday life.1,2 As indicated by the 
terminology, neurological as well developmental disturbances are assumed as their causes, 
although the exact mechanisms and pathways driving the phenotypes are still unknown. The 
literature to date confirms that NDD phenotypes are related to disturbances in brain structure 
and functioning, affecting the development of motor-, sensory-, language-, social- and 
cognitive skills.3,4 In the current and 5th edition of the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-5), an umbrella concept of NDD is introduced for the first time,5 
emphasizing the significance of abnormal neurodevelopment in the etiology of Autism 
Spectrum Disorder (ASD) and Attention-Deficit/Hyperactivity Disorder (ADHD). The NDD 
category in DSM-5 includes, besides ASD and ADHD, intellectual disability (ID), 
communication-, specific learning- and motor disorders.6  
1.1.1.2 Autism Spectrum Disorder 
ASD is defined by impairments in the areas of verbal and non-verbal communication, social 
reciprocity and interaction, and by stereotyped and repetitive behaviors and interests. Autistic 
phenotypes were described already in the 1940s by Leo Kanner and Hans Asperger.7,8 In 
Kanner’s article, based on a detailed description of eleven children with autistic features, he 
makes the conclusion that the fundament of their impairments is “the children’s inability to 
relate themselves in the ordinary way to people and situations from the beginning of  
life”.7, p 242 Further he notes “…these children have come into the world with annate inability 
to form the usual, biologically provided affective contact with people, just as other children 
come into the world with annate physical or intellectual handicaps”.7, p 250 Autism has over 
time been one of the most stable psychiatric diagnoses in terms of core symptoms, although 
the criteria for the disorder have become more and more inclusive. In contrary to the 
behavioral criteria, the view on the causes of autism has been shifting. Autism was already 
with the first descriptions of the phenotype suggested to be familial.7,8 Later, for decades, it 
was viewed as environmentally caused, mainly through callous and emotionally distant 
mothers. This view was questioned by results from the first valid twin studies in the 1970s, 
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reporting substantially higher concordance in monozygotic (MZ) compared with dizygotic 
(DZ) twin pairs, and indicating a high heritability.9 Numerous twin studies have thereafter 
confirmed a strong genetic component in the etiology of autism, for categorical diagnoses as 
well as autistic traits, reporting heritability estimates as high as 80-90%.10 However, lately the 
high heritability in ASD has been questioned, and a more equal distribution between genes 
and environment is suggested,11,12 with the environmental components comprising pre-, peri- 
and early postnatal factors.13  
Autism is heterogeneous in phenotypes as well as functional deficits. Severity ranges from 
high-functioning expressions (e.g., many previously diagnosed with Asperger’s syndrome), 
to low-functioning individuals with no or little language and typically, comorbid intellectual 
disabilities. Nevertheless, an ASD diagnosis always implies impairments in one or several 
areas of daily life.1 The literature supports autistic phenotypes to be continuously distributed 
in the population, with clinical diagnoses representing extremes on this continuum.14-16 In the 
DSM-5, the previous separate diagnoses within the spectrum (i.e., Autistic Disorder, 
Pervasive Developmental Disorder Not Otherwise Specified, Asperger’s Syndrome, and 
Childhood Disintegrative Disorder), are merged into one ASD diagnose. Of note, the Rett’s 
Syndrome which is characterized by a known molecular etiology, is defined as a separate 
diagnose. Severity levels are specified based on the degree of required support in two areas of 
symptoms; i) social communication and ii) restricted, repetitive behaviors. The accumulated 
genetic and environmental evidence in ASD is acknowledged, by adding a specifier of known 
genetic or environmental conditions to the diagnostic criteria, alongside specifiers for 
intellectual disability and language impairment.5 
1.1.1.3 Attention-Deficit Hyperactivity Disorder  
ADHD, also known as hyperkinetic disorder, is characterized by inattention and/or 
hyperactivity and impulsivity problems. One of the first descriptions of the phenotype was 
made in 1775 by a German physician, Melchior Adam Weikard.17 Since then, the knowledge 
and evidence of the diagnosis and treatment has been growing. In DSM-5, three presentations 
of ADHD symptomatology are described: predominantly inattentive, predominantly 
hyperactive-impulsive, and the combination of the two areas, with additional unspecified 
presentations. The severity of impairments is ranked from mild to severe, with a specification 
if in partial remission.5 Although not part of the diagnostic criteria, central areas of deficits 
are also executive dysfunction and impaired emotion regulation. The cognitive profiles within 
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ADHD vary widely. Most individuals have impairments in some behavioral domains and 
only a minority are impaired in all the above mentioned areas.  
In addition to the DSM-5 subgroups (i.e., based on the summed number of criteria in each 
symptom domain), attempts have been made to identify phenotypical subgroups based on 
biological markers and related traits. Six alternative subgroups, based on temperament 
dimension and with different biological underpinnings, have been identified. These were 
calculated from community detection and based on graph theory combined with functional 
magnetic resonance imaging (fMRI) and physiological measures. It is suggested that these 
subgroups would better represent differences in etiology, than the current diagnostic 
categories.18,19 As for ASD, the literature supports ADHD phenotypes to be continuously 
distributed in the normal population, with clinical diagnoses as the extremes.20  
1.1.1.4 Prevalence 
There are no good worldwide prevalence estimates available for NDDs in total, but data from 
the United States indicates a frequency of 12% in the general population.21 In the past decade, 
an increasing prevalence has been reported for both ASD and ADHD.22,23 Current estimates 
of ASD are 1–2%, and the figures are stable over the life span.24,25 The prevalence of ADHD 
is around 5% in school-children,26 and diminishes up in adult age. Hence, many adults 
express a number of ADHD symptoms on a subclinical level, but are not longer filling 
criteria for diagnosis.27 
The origins of the increased prevalence of NDDs are debated. Improved knowledge and 
increased awareness, access to better services, and reduced stigmatization might be important 
factors.28 One longitudinal Swedish twin study showed no real increase in ASD prevalence 
numbers over a 10-year period. They collected two types of ASD measures over the 10-year 
period; a parental telephone interview and clinical diagnostic data from national registers. A 
comparison between the measures showed an increase in registered clinical diagnoses, but 
stable figures of ASD as measured the telephone interview. The findings suggest the 
increasing prevalence numbers to be explained by changes in clinical procedures of 
diagnosing, rather than reflecting a real increase of ASD in the population.29  
The increase in ADHD prevalence is at least partly due to alterations of the diagnostic criteria 
for ADHD with the 5th edition of DSM (i.e., change of the age for onset from seven to 12 
years).3 If there is also a true increase in prevalence, due to for example environmental factors 
such as exposure to environmental toxins or toxic metals, it is still to be confirmed.30,31  
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1.1.1.5 Sex Differences 
There is a skewed sex distribution within ASD (all ages) and ADHD (in children) in which 
males are affected 2–4 times more often than females.3,32 
Differences in ASD phenotypes between males and females have been reported, such as more 
prominent repetitive and stereotyped behaviors in males.33 In contrast, diagnosed females 
often present with more severe variants of ASD, and comorbidity with intellectual disability 
(ID) is more frequent.34 Consequently, the sex ratio of ASD has been reported to be almost 
equal in the low IQ range, while being highly skewed towards males in the upper range of 
intellectual abilities.35 It has been suggested that the diagnostic criteria favors male 
phenotypes, resulting in only the most severely impaired females reaching cut-off for 
diagnoses.36  
One of the most cited theories on gender and ASD is Simon Baron-Cohens’ of an extreme 
male brain.37 It is supported by studies showing individuals with ASD to present with 
increased systemizing (male feature), combined with decreased empathizing (female feature). 
The theory hypothesize a masculinization of the brain to occur during the fetal brain 
development by elevated levels of prenatal androgens and potential involvement of the X- 
and Y-chromosomes in the etiology.37,38 However, the evidence for this extreme male brain 
theory of autism, is inconsistent.32,39  
While the skewed sex ratio is stable over the life span in ASD, the distribution becomes 
closer to equal between males and females in adult age in ADHD.3 Like ASD, there are 
phenotypical differences in ADHD with girls displaying greater intellectual impairments 
combined with less symptoms of hyperactivity and other externalizing problems.40 A 
functional brain imaging study showed sex-related differences in neural activity linked to 
ADHD. Brain connectivity was measured during a working memory task with findings of 
altered patterns of neural activity in males with ADHD, but not in females with ADHD.41 
Genetic studies favor a polygenetic threshold model for both disorders that varies with sex. 
The model hypothesize the female sex to be a protective factor for the disorders, and girls to 
have a higher threshold for the genetic liability to manifest ASD and ADHD.42-44 This model 
is supported by females presenting with more severe phenotypes, as well as findings of 
affected females having a higher degree of affected relatives in comparison to affected males 
(assuming a familiar transmission).32,45,46  
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1.1.1.6 Comorbidity 
Comorbidity is high in NDDs.3,4 The overlap between ASD and ADHD is in the range of 28-
44%. In ASD, comorbidity with intellectual disability is common (~45%), as well as tic 
disorders (14-38%), anxiety (42-56%), and depression (12-70%).4 In addition, individuals 
with ASD often suffer from somatic conditions such as epilepsy (8-30%), gastrointestinal 
problems (9-70%), and sleeping disorders (50-80%). A recent epidemiological study showed 
a markedly increased mortality in ASD in comparison to the general population with and 
odds ratio (OR) of 2.56, and 95% confidence interval (CI) between 2.38 and 2.76. The 
authors concluded the increase to be caused by a range of co-occurring somatic conditions.47  
A meta-analysis of ADHD yielded a 10.7-fold risk for conduct disorder, 5.5-fold risk for 
depression and 3-fold risk for anxiety, in comparison to the general population.48 ADHD 
symptoms are further associated with an increased risk of stressful life events (OR=1.8, 95% 
CI 1.3-2.4).49 An increased mortality is assumed, owing to high levels of impulsivity, 
accidents, smoking and drug use, although more epidemiological studies confirming these 
results are needed.50 
The high overlap between ASD and ADHD have been modelled in different ways: i) as three 
independent disorders (i.e. ADHD, ASD, and ASD-ADHD combined); ii) as two disorders 
with alternating manifestations of the same underlying factors; iii) as a few correlated risk 
factors for the disorders.51 Support for all three models can be found in the literature to date, 
leaving it to future research to determine which model best describes the true etiological 
relationship.52  
1.1.1.7 Intelligence Quotient (IQ)  
Even though co-occurrence with ID is common, ASD appears on the full range of 
intelligence.53 High IQ is one of the strongest predictors of functional outcome in ASD in 
terms of employment, higher education, social relationships and independent living.54 ASD, 
in combination with low IQ (<70), is almost exclusively accompanied by poorer outcomes, 
such as relaying on family and social services for every-day living, lack of permanent 
employment, few friends, and poor communication-, reading- and spelling abilities.55  
Despite the overlap between ID and ASD, few studies have investigated the etiology of the 
overlap, and mixed findings are reported. A high genetic correlation of 0.95 (95% CI .60-
1.00) for the phenotypical overlap was found in a small Japanese twin sample (N=45 pairs). 
A considerable lower genetic correlation have been reported from two studies based on the 
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Twin Early Development Study (TEDS) cohort ranging from -0.04 to -0.27.56,57 The latter 
studies suggest autistic traits in the extremes and the normal range are substantially 
genetically independent of IQ.56 Common genetics have also been indicated for ASD and IQ 
in molecular genetic studies, with many genes predisposing for both conditions.58 Also 
environmental factors such as perinatal risk factors (i.e. gestational age, birth weight and 5-
min Apgar score) have been associated with both ID and ASD.59 Common epigenetic causes 
are suggested. There are findings of factors such as prenatal exposure to valproate (primarily 
used to treat epilepsy, bipolar disorders, and migraine) causing epigenetic dysregulation that 
potentially are linked to both ID and ASD risk.60 
A weak link has been shown between ADHD and IQ, in the magnitude of two to eight IQ 
points lower in individuals with ADHD than controls.61 A meta-analysis including 18 studies 
on the topic showed a significant, but not clinically relevant, effect of slightly lower IQ in 
ADHD cases compared to controls. The results suggested only a subset of the ADHD group, 
also presenting with comorbid disorders, to have lower IQ than the general population.62  
1.1.2 Diagnostic Assessments 
Both ASD and ADHD are behaviorally defined disorders. For diagnostic evaluations, 
multidisciplinary assessments are recommended, including anamnestic information and 
assessments of symptom severity, neurocognitive and intellectual abilities, and every-day 
functioning. 
1.1.2.1 Diagnosis of ASD 
Symptoms of ASD are measurable from the age of 12 months.63 Still, most cases are 
diagnosed considerably later,24 as early behavioral measures are limited in sensitivity and 
specificity.64 As early identification ensures access to intervention with increased chances for 
improved outcomes, establishing reliable early detection of ASD remains a clinical  research 
priority.65 The first choice diagnostic instruments for ASD assessments are the Autism 
Diagnostic Interview – Revised (ADI-R),66 in combination with the Autism Diagnostic 
Observation Scale (ADOS).67,68 Both instruments have shown good psychometric properties, 
in particular when combined.69-71 The ADI-R is a semi-structured anamnestic interview with 
the caregiver as respondent, focusing on early and present symptoms in the areas of social 
reciprocity, communication, repetitive behaviors and interests, and early developmental 
delays. The ADOS is a semi-structured observation, that samples and quantifies an 
  15 
individual’s behavior in a naturalistic setting. Both ADI-R and ADOS provide diagnostic 
classifications as well as dimensional scores. 
1.1.2.2 Diagnosis of ADHD 
Early symptoms are typically unclear and interpreted as insufficient maturity in ADHD, and 
early screening is less emphasized than in ASD. Still, a six year long study indicated that 
screening with parent-rated questionnaires promote earlier detection of impairments.72 
ADHD assessments include information from anamnestic and diagnostic interviews, such as 
Schedule for Affective Disorders and Schizophrenia School Age Children (K-SADS)73 and 
Diagnostic Interview for ADHD in adults (DIVA).74 These assessments might be combined 
with caregiver-, teacher- or self-rated symptom scales, neuropsychological testing, and 
assessment of adaptive functioning.  
Since both ASD and ADHD phenotypes are continuously distributed, categorical (for 
assessment of diagnosis) as well as continuous (for assessments of traits) measures are 
needed to capture the entire phenotypes. Dimensional traits are typically measured by 
continuous caregiver- or self-rated scales such as the Social Responsiveness Scale (SRS) for 
autistic traits,75 and the Conners for ADHD traits.76  
Comorbidity is common in both disorders, hence assessments of other psychiatric and 
somatic symptoms are essential in the diagnostic evaluation. Assessment of comorbidity 
might include interviews and/or rating scales for psychiatric disorders, medical 
examinations, medical anamnestic information, and when applicable, magnetic resonance 
imaging (MRI) of the brain, and genetic testing, for exclusion of other neurological and 
genetic disorders. 
1.1.3 Treatment 
There are various behavioral interventions for ASD symptoms, including applied behavioral 
analysis (ABA) based treatments, structured teaching, skilled- and behavior-based 
interventions, interventions addressing anxiety and aggression, and early parent-mediated 
interventions. The effects of these interventions on core ASD symptomatology are low to 
moderate.4,77,78 There are no pharmacological treatment available for the core ASD 
symptomatology, although related symptoms such as anxiety and sleeping problems can be 
treated with a positive effect on the individual’s general functioning, and indirectly on ASD 
symptoms.79  
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In contrast, pharmacological interventions are the most efficient treatment alternatives in 
ADHD. Meta-analysis support both stimulants and non-stimulants to effectively reduce 
ADHD symptoms in children as well as in adults.80 There are two types of stimulants used, 
methylphenidate and amphetamine products, both blocking dopamine transporters (see below 
for a more details on the role of dopamine in ADHD). Amphetamine products also promote 
the release and reverse transport of dopamine. For non-stimulants, the most effective 
medication is a selective noradrenaline reuptake inhibitor. A review of 351 studies on long-
term treatment effects in ADHD reported significantly improved outcomes with treatment, in 
comparison to untreated individuals with ADHD, although not reaching the level of non-
affected individuals.81 However, one meta-analysis of methylphenidate treatment in ADHD, 
also report uncertainty regarding the magnitude of treatment effects (due to low quality of 
underpinning evidence), and associations between methylphenidate and adverse events such 
as sleep problems and decreased appetite.82 Non-pharmacological treatments for ADHD 
include dietary and behavioral treatments.83,84 The results from clinical trials of non-
pharmacological treatments in ADHD show substantially smaller effect-sizes than for 
pharmacological interventions, on the other hand, they induce minimal risk of reverse 
events.80   
1.1.4 Neurobiology 
Neuroimaging, in combination with molecular genetics, points at atypical neural connectivity 
in ASD. The literature reports on various and heterogeneous brain functional connectivity 
alterations, among which the reduced long range versus increased short range (frontal) 
connectivity is the most popular.85,86 Some findings suggest reduced functional connectivity 
to be associated with multiple cognitive impairments such as language, working memory, 
problem solving, social cognition, and social perception.87 Diffusion tensor imaging (DTI) 
has demonstrated alterations mostly in associative white matter fiber bundles connecting 
different brain regions, which subtend high-level cognitive functions (e.g., social cognition, 
language) in ASD.87 
In addition, there are anatomical findings that are frequently reported in ASD. The most 
popular is an early brain overgrowth, observed between six and 24 months of age. A meta-
analysis of head circumference and brain size in ASD indeed showed that both head 
circumference and total brain volume were significantly larger in ASD cases compared to 
controls. The effect sizes were higher in low-functioning groups in comparison to high-
functioning, and largest in early childhood.88 However, a study on the Californian Autism 
Twin Study (CATS) (see below for a more detailed description of the CATS sample), showed 
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no association between ASD and head circumference.89 Further structural alterations have 
been reported, including changes in white matter volumes and abnormal growth in the frontal 
lobe, temporal lobes, and limbic structures, such as the amygdala.90  
Findings from neurochemical studies with animal models and pharmacological studies are 
inconclusive in ASD. Genetic differences in serotonin transportation seem to have the most 
empirical support for a role in ASD etiology.90 A gamma-aminobutyric acid (GABA)-
glutamate (i.e. an inhibitory/excitatory) imbalance is also suggested to be associated with 
ASD, although studies investigating this hypothesis have reported contradictory results.91  
Several brain regions and functional pathways have been implicated in ADHD. Meta-analysis 
on structural MRI studies in ADHD have reported on smaller total brain volume (3-5%), due 
to reduction of grey matter. In particular smaller volumes in the right globus pallidus, right 
putamen, caudate nucleus and cerebellum are linked to ADHD. Interestingly, data supports 
pharmacological treatments to reduce the structural brain alterations in ADHD patients.92 
Functional MRI studies have examined brain activity during tasks calling attention, inhibitory 
control, and working memory in ADHD subjects. These studies have reported on an under-
activation in the frontoparietal network, involved in goal-directed executive processes, in the 
frontostratial network, mediating reorientation of attention, and the ventralstratial network, 
which is related to reward-processing. In addition, a hyper-activation in somatomotor and 
visual systems has been reported.3 
Some of the most robust neurobiological findings in ADHD relate to alterations in dopamine 
receptors. Dopamine has a central role in the regulation of motor activity, motivation, 
inhibitory control, timing and attention functions. The striatal dopamine transporters are the 
target for the two most commonly used drugs in ADHD: methylphenidate and 
amphetamine.93 A meta-analysis including studies using positron emission tomography 
(PET) and single photon emission tomography (SPECT) to study dopamine in ADHD, 
reported the striatal dopamine density to be 14% higher in ADHD cases compared to 
controls. In addition, the dopamine density was higher in ADHD patients with previous 
medication  in comparison to drug-naïve patients.94 Genetic studies support this hypothesis. 
Although together with a large number of other candidate genes, dopamine transporter and 
receptor genes have been reported to be among the most important genes in ADHD 
etiology.95  
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1.1.5 Neuropsychology 
There are several psychological and neurocognitive theories modelling the impairments in 
ASD and ADHD. Below is a non-exhaustive list of some of the more popular ones.  
1.1.5.1 Social Cognition/Theory of Mind  
The concept that autistic individuals lack a “theory of mind” was first introduced in 1985.96 
The theory of mind refers to an ability of meta-representation and to attribute beliefs in 
others, predicting their thoughts and actions. It implies that individuals are unable to 
differentiate between physical states (objects) and mental states (persons), and an inability to 
ascribe mental states in self as well as in others, resulting in multiple difficulties related to 
social interaction.97 A crucial step in development of these abilities is the understanding of 
false believes. The Sally and Anne task is a widely used test for false belifes.98 In the test the 
child is shown two dolls, Sally and Anne, whom have a basket, a box and a toy. Sally puts the 
toy in the basket and leaves the room. When Sally is out, Anne moves the toy to the box. The 
child is then asked where Sally will look for the toy when she returns. By answering the 
basket, the child shows an understanding of the mental representation of Sally, which is 
different from the child’s own (who knows that the toy is moved to the box), and make a 
prediction of the behavior of Sally based on this understanding. Children with ASD have 
larger difficulties to pass this test in comparison to e.g. typically developed children or 
children with Down’s syndrome.96 In support of this, fMRI studies show altered activity in 
prefrontal cortex and in the right tempoparietal junction during theory of mind tasks in ASD 
cases, in comparisons to controls,99 and eye-tracking studies have shown altered tracking in 
ASD cases during false belief tasks, in comparison to controls.100 
1.1.5.2 Weak Central Coherence  
Although the Theory of Mind hypothesis well describes the social challenges in ASD, it does 
not clearly address communicational problems or the repetitive and stereotyped behaviors. 
Weak central coherence refers to a cognitive style with enhanced detail-focus and failure to 
extract global form and meaning. It was introduced as an attempt to also capture the non-
social impairments in ASD.101 A review of over 50 studies on the topic give robust evidence 
for local bias in ASD, but mixed results regarding weak global processing. The authors 
suggest weak central coherence to be a biased cognitive style, rather than a deficit, and to 
explain the non-social features in ASD.102 
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1.1.5.3 Dual and Triple Pathways-models of ADHD  
In addition to executive dysfunction, non-executive deficits are present in ADHD such as 
altered reward and aversion signaling leading to impulsivity. The delay aversion construct is 
defined as an emotional and motivational response style described as a “negative emotional 
reaction to the imposition of delay”.103, p 103 Delay aversion has been tested in a range of 
studies, showing individuals with ADHD to have a tendency of choosing smaller and sooner, 
over larger and later rewards.104 ADHD phenotypes are heterogeneous and it is common to 
demonstrate deficits in one of the two areas of symptoms exclusively, suggesting a dual 
pathway. The dual pathway proposes executive versus non-executive phenotypes to be 
caused by different etiological pathways: the first being a dorsal fronto-striatal dysregulation 
mediated by inhibitory executive dysfunction. The second being underpinned by ventral 
fronto-striatal circuits and linked to the delayed reward/aversion processing.105 In addition, 
Sonuga-Barke and colleagues have proposed a triple pathway model; i) inhibition, ii) timing 
and iii) delay. They have showed subgroups within ADHD to be impaired in only one of 
these three areas, hence suggesting separate etiologies are suggested for the three domains. 
The results point at genetic underpinnings for inhibition and timing, and a more 
environmentally driven etiology for impaired delay functions.106  
1.1.5.4 Executive Functions in ASD and ADHD 
There are overlapping deficits in ASD and ADHD, and most prominent is executive 
dysfunction. Executive functioning directs goal-directed cognitions including planning, 
working memory, problem solving, mental flexibility, and decision making. These abilities 
enable independent and purposeful every day functioning, affecting all areas of life including 
social relationships, academic- and work achievements.107 
Executive dysfunction is frequently reported in individuals with ASD. This holds especially 
true for cognitive inflexibility, reported as a life-long complication of ASD.108,109 Areas of 
working memory, initiation and organizational functions typically become more problematic 
when individuals with ASD become older and due to the rising demands of independence.109  
Behavioral inhibition and working memory are proposed as core underlying difficulties in 
ADHD,110 with neurobiological correlates including alterations in the frontal lobes, caudate 
nucleus, and cerebellar vermis.111 
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1.2 ETIOLOGY 
1.2.1 Behavior Genetics 
Behavior genetics is the study of the relative distribution of genetic and environmental 
contributions to behavioral phenotypes. It is based on the underlying notion that if a trait or a 
disorder is heritable, individuals that are more genetically similar should also be more similar 
regarding that trait or disorder status. By studying individuals with different degrees of 
relatedness and/or environmental exposure (e.g. twin designs, adoption designs), estimations 
can be made of the relative effect of genes (heritability) and environment on behavioral traits.  
1.2.1.1 Heritability, Shared and Non-shared Variation 
Twin modelling is taking advantage of the fact that monozygotic (MZ) twins share 100% of 
their genetic variation on deoxyribonucleic acid (DNA) sequence level, while dizygotic (DZ) 
twins share on average 50% of their genetic variation. By comparing MZ and DZ pairs, the 
relative distribution of Additive genetics, Common environment, and unique Environment 
can be modelled (ACE).112  
Two categories of environmental factors are explored in behavior genetics: environmental 
factors shared by family members, making them similar (e.g. prenatal factors, sex, age, 
socioeconomic status) and environmental factors not shared between family members (NSE), 
making them dissimilar (e.g. medical events, dietary, traumatic life events). In addition to 
NSE, there are stochastic de novo mutations potentially adding to intra-pair differences. 
However, these mutations are rare and usually not taken into account in twin modelling.  
1.2.1.2 The Limitations of Twin Designs 
Twin designs are powerful in etiological research, however, there are some limitations that 
need to be addressed.   
Two assumptions are made in twin-modelling: i) the equal environment assumption, 
assuming no difference in environmental effects between MZ and DZ pairs; and ii) the non-
appearance of assortative mating, assuming that parents do not choose partners being 
phenotypically more similar to themselves. If the assumption of equal environment is in any 
way violated, the heritability estimates would be affected, most likely leading to an 
overestimation of the heritability. However, this assumption has been tested and proven to be 
reasonable for most traits.e.g. 113 Possible exceptions are prenatal factors. MZ twins are more 
often affected by prenatal factors than DZ twins, particularly if the twins are sharing the same 
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chorion. These pairs will in most cases experience a higher intra-pair prenatal competition, 
presumably resulting in greater environmental effects than DZ pairs (e.g., for birth weight).114 
If the assumption of no assortative mating is violated, the DZ pairs would share more than 
50% of their genes due to their parents being more genetically similar, while the genetic 
similarity for MZ twin pairs would be unaltered. A few studies have investigated the degree 
of assortative mating in ASD with mixed findings.e.g. 15 Ronald and Hoekstra10 argue that 
since the intra-pair correlations are higher in studies using spousal report,e.g. 115 compared 
with studies using self-report,e.g. 57 the similarity between partners are more likely to be due to 
shared values and common beliefs, rather than shared genetic effects. However, more studies 
with broader family designs are needed to further investigate the occurrence of assortative 
mating in ASD/ADHD.  
In within twin-pair comparisons, there might be a risk of a sibling interaction effect.116 This 
can either be cooperative or competitive, leading either to increased or decreased similarity 
between the twins. The effect can be reflective of a true relationship, due to tendencies in the 
twins to either differentiate or to influence each other. It can also be due to parental rating 
patterns, and parents to either emphasize the differences or the similarities between their 
children. If the effect is cooperative, it will increase the variance in both MZ and DZ pairs, 
but more in MZ, and if the effect is competitive, it will decrease the variance in both groups, 
but again with a larger effect in the MZ pairs.116 This has particularly been demonstrated in 
twin difference designs focusing on discordancy using parent reports.e.g. 39  
An often discussed limitation of twin designs is the generalizability of results from twin 
samples to non-twin populations. For instance, it has been suggested that twinning itself 
could be a risk factor for ASD. However, when tested in two UK population-based samples, 
the opposite was found for dimensional as well as categorical ASD.117 The same has been 
shown for related abilities such as IQ and academic performance, reporting no differences 
between twins and singletons, when adjusting for birth weight.118 
1.2.2 Nature vs Nurture   
An increasing number of twin studies in the past decades have contributed substantially to the 
understanding of the etiology of ASD and ADHD, demonstrating both genetic and 
environmental contributions.10,20 
Heritability estimates for ASD range from 38-55%,11,12 and up to 95%.14 Although one twin 
study claims shared environment to play a major role in ASD etiology,12 most literature 
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supports NSE to be the predominant environmental factor.10,11 These results have been 
replicated in the normative range as well as in extreme phenotypes and for different age 
groups.10,119 The literature support two or three symptom domains to constitute ASD, with 
partly different etiologies.120 A population-based Swedish twin study suggest a common 
pathway for the triad of ASD symptom domains, but also genetic influences that are separate 
for each domain.121 
The heritability in ADHD is estimated somewhere between 67% and 88%, in both children 
and adults.122 However, one longitudinal twin study including >600 twin pairs reported on an 
increasing heritability with age, from 33% (age three years) to 67% (age 13 years).123 A 
recent population based study including >59 000 Swedish twins estimated heritability to 88% 
in the total population and slightly less, 72%, in adults only. While previous twin studies have 
reported higher heritability estimates in females,46,124 no sex related difference for the 
etiological components were found in the Swedish cohort. The environmental effect is due to 
NSE factors, and no or limited effects of shared environment are reported.125 The two core 
domains of symptoms, inattention and impulsivity/hyperactivity, are both strongly influenced 
by genetic factors (71% and 73%, respectively). The type of genetic effect differ though, and 
dominant genetic effect is more prominent for inattentive symptoms, and additive genetic 
effect for impulsivity/hyperactivity.126  
There is a genetic overlap between ASD and ADHD, and 50-72% of the phenotypic variance 
is estimated to be due to additive genetics shared between the disorders.127 A Swedish twin 
study of >17 000 twins investigated the overlap between different symptoms domains in 
ASD/ADHD. They found the largest overlaps, phenotypic as well as genetic, to be between 
repetitive and restricted symptoms and hyperactive/impulsive as well as inattentive 
symptoms, with genetic correlations of 0.61-0.64.128 However, exploration of the shared 
etiology of the disorders has been limited by a restriction in the DSM-IV, not allowing 
concurrent ADHD and ASD diagnoses. This is now changed in the present DSM-5, and will 
hopefully lead to more research and a better understanding of shared causal mechanisms as 
well as clues for enhanced treatment options for patients with both disorders. 
1.2.2.1 Genetic Factors 
Although considerable progress in genetic research in ASD during the past decade, and a 
rapid methodological advancement in the field, the genetic causes of ASD are still largely 
unknown.129 A minority of individuals with ASD (~15%) have an identifiable single-gene 
disorder, such as fragile X, tuberous sclerosis or neurofibromatosis, which may account for 
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the phenotype. In addition, recent advances in genome-wide methods including detection of 
copy number variations (CNVs) and single nucleotide polymorphisms (SNPs) from 
sequencing studies, have revealed multiple genes and variants linked to ASD risk.130 The 
majority of findings have emerged from de novo CNVs and single nucleotide variations 
(SNVs) affecting genes involved in synaptic functioning, and chromatin modification. 
Estimates suggest the existence of at least several hundred ASD risk genes.131 
Genome-wide association studies (GWAS) report around 40% of the heritability in ADHD is 
due to common genetic variants, and the remaining are due to CNVs and rare genomic 
insertion and deletions (<1%).3 Identified ADHD relevant genes are involved in 
dopaminergic, noradrenergic, serotonergic, cholinergic, and the central nervous system 
(CNS) development pathways.95  
The literature shows various genetic effects to influence both ASD and ADHD phenotypes. 
Some of the risk alleles seem to have a pleiotropic effect, meaning they can result in either 
ASD or ADHD, while others are disorder specific.52 
1.2.2.2 Environmental Factors 
In addition to a strong genetic component in the etiology of ASD and ADHD, twin studies 
consistently point at a NSE factor in their etiology. In line with an early developmental 
pathogenesis, the literature suggests pre- and perinatal factors to be the dominant 
environmental risk factors for NDDs.  
Multiple single environmental factors have been implicated in ASD, including parental age, 
birth injury and trauma, gestational diabetes, neonatal anemia, maternal valproate intake, and 
exposure to toxic chemicals, especially during the third trimester.13,132,133 A British study 
including >13 600 twins found only a weak correlations between total neonatal problem load 
and autism traits.134 Maternal intake of periconceptional folic acid supplements is reported to 
have a protective effect.60 Exposure to metal toxicants, is potentially increasing ASD risk.31 
For example, one study investigating hair metal concentrations of ASD cases, showed 
reduced zinc and magnesium levels and elevated levels of toxicants, such as lead, associated 
with ASD.135 The lead hypothesis is supported by findings of enhanced levels in blood.136  
Animal studies suggest the gut to influence various behaviour linked to ASD phenotypes137 
and gastrointestinal problems are common in ASD patients.138 Although most of the 
mechanisms by which the microbiome can affect the brain and human behaviour are still to 
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be established, the possibility of microbe based treatments for ASD has attracted a lot of 
attention.138  
In ADHD, a strong genetic effect is suggested for the onset of the disorder, and 
environmental factors to affect the degree of the behavioral compensatory strategies defining 
the persistence. Mainly pre- and perinatal factors have been associated with ADHD, such as 
low birth weight, prematurity, in-utero exposure to maternal stress, maternal smoking, and 
maternal alcohol and prescribed drug intake. However, evidence of causal relationship has 
only been shown for low birth weight, while the others might be due to unmeasured 
confounding factors.3,139 Associations between environmental toxins, such as early childhood 
exposure to lead and pesticides, have been linked to ADHD risk. Dietary and psychosocial 
factors have been suggested to increase ADHD risk, however the findings are inconclusive.139 
There are overlapping risk factors for both ASD and ADHD such as low birth weight, 
prematurity and maternal exposure to environmental toxins.3,4,46,140 Exposure to air pollution 
has been suggested to increase NDD risk, and to add to the increasing prevalence.141 Yet, a 
recent population-based Swedish twin study including >3000 twins found no associations 
between pre- and postnatal exposure to air pollution and neither ADHD nor ASD risk.30 
1.2.2.3 Epigenetic Mechanisms  
The literature show environmental factors in ASD and ADHD to mainly act via gene-
environment interaction (GxE), such as epigenetic dysregulation.142,143 Epigenetic 
mechanisms are modifications of gene expression, controlled by something other than the 
DNA sequence, that are potentially reversible. These factors are influenced by the 
maturational stage, tissue type, and environment. There is evidence that dysregulation of 
epigenetic markers or mechanisms, such as DNA methylation, play a significant role in ASD 
and ADHD etiology, integrating genetic and environmental factors to dysregulate 
neurodevelopmental processes.60,144,145 One factor that might cause epigenetic dysregulation 
is prenatal programming, caused by a stressful in-utero environment. The programming is 
dependent of the type and timing of exposure, the sex of the fetus, and is depending on 
cognitive inputs from the environment.146 Literature, primarily based on rodent studies, have 
proposed a three-hit concept of vulnerability and resilience to maternal stress. The first hit is 
the effect of genetic disposition, the second hit is the effect of the prenatal environment, and 
the third hit is an altered genetic expression leading to phenotypes with differing vulnerability 
to later exposure.147 A population-based Swedish study including almost three million 
individuals, examined the associations between maternal stress and ASD/ADHD diagnoses. 
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They found maternal bereavement during the third trimester to increase the risk of both 
disorders, with an adjusted hazard ratios of 1.58 for ASD and 1.31 for ADHD.148   
There are methodological challenges in the field. Nevertheless a rapid development of 
techniques using induced pluripotent stem (iPS) cells and facilitating sophisticated in vivo 
modelling of epigenetic mechanisms, might lead to novel discoveries in the future.149 
1.2.2.4 A Cumulative Multifactor Threshold Model 
The literature favors a multifactorial causal model for both ASD and ADHD, with a variety 
of possible etiological pathways leading to the phenotypes. Evidence points at an interplay 
between genetic and environmental factors, effecting development of the CNS and immune 
system.150,151 In ASD, the timing of events is considered decisive with certain critical time 
windows associated with increased or decreased susceptibility. The cumulative degree of risk 
factors has been correlated to the severity of traits, suggesting future research to focus on the 
combined risk factor profiles, rather than trying to identify specific causal agents.152  
1.2.3 Twin Difference Designs 
A powerful design for exploration of NSE is the assessment of twins discordant for the 
phenotype of interest, also called twin difference or co-twin control design.153 Particularly 
powerful is the investigation of MZ twin pairs discordant for disorders or traits that are 
assumed to have a high heritability. Since MZ pairs are identical on a DNA sequence level, 
the design implicitly controls for genetic factors in addition to all other factors being shared 
within twin pairs. Therefore, differences within the pairs must be due to NSE (including 
epigenetic mechanisms), rare de novo genetic mutations, or measurement errors. In highly 
familial disorders, such as ASD and ADHD, MZ discordant pairs are rare, making 
recruitment of participants challenging. To date only a moderate number of studies have 
particularly addressed MZ pairs discordant for these disorders, and they are in general of 
small sample size and limited generalizability.  
1.2.3.1 Discordant MZ Twin Pair Design Studies in ASD 
A handful of studies have examined neurological differences in ASD discordant pairs. 
Among those, Kate and colleagues published four studies on structural brain imaging in 
partly overlapping samples including from one up to 15 MZ discordant pairs, and various 
numbers of controls.154-157 The findings show reduced caudate, amygdala, hippocampus and 
cerebellar volumes, and differences in cortical folding in the partial lobes in ASD twins.  
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Two studies of MZ pairs discordant for ASD have examined gene expression.158,159 The 
findings show the most differentially expressed and methylated genes in discordant pairs are 
genes related to development, function and structure of the CNS. Many of the affected genes 
also map closely to chromosomal regions containing previously reported autism candidate 
genes. Quantitative discordance (i.e., intra-pair differences on continuous measures for ASD 
traits) has been assessed in the British Twins Early Development Study (TEDS) cohort.144 In 
this study, the authors listed the top 50 differentially-methylated probes associated with ASD, 
indicating a large heterogeneity of epigenetic factors potentially involved in ASD 
pathogenesis. One case study of an ASD discordant pair (one twin with ASD, and one twin 
with developmental delay and hyperactivity) showed a genetic discordance, reporting a 
2p25.3 deletion in the non-ASD twin. A mitotic non-allelic recombination is suggested to 
have occured during blastomeric divisions of the zygote, resulting in a chromosome 
imbalance causing the phenotypical discordance.160  
1.2.3.2 Discordant MZ Twin Pair Designs in ADHD 
Also for ADHD, there is a limited number of studies based on discordant MZ twin pairs. The 
studies have proved early environmental factors such as birth weight, delayed physical 
growth, motor development and being second born in the pair, to be associated with ADHD 
risk.140,161-163 Two discordant twin pair studies have explored brain alterations in ADHD, the 
first linking structural differences (i.e., reduced caudate nucleus and prefrontal lobes 
volumes) to ADHD.164 The second explored brain activation while performing executive 
functioning tasks, and showed both decreased activity (in dorsolateral prefrontal, parietal and 
temporal brain regions) and increased activity (in premotor cortex and regions associated 
with visual selective attention processing) to be associated with ADHD.165  
One study investigated the effect of de novo and inherited CNVs on ADHD risk. They found 
one pre- and one post-twinning CNV to be associated with ADHD, and an association 
between overall larger CNVs and increased ADHD risk.166 
1.3 SUMMARY  
ASD and ADHD are complex neurodevelopmental disorders with heterogeneous phenotypes 
as well as etiology. No reliable biomarkers are available for neither of the disorders, hence 
both ASD and ADHD are exclusively behaviorally defined. Most patients are diagnosed 
much later than the appearance of first symptoms, decreasing the possibility of successful 
behavioral treatment interventions, particularly in ASD. There are effective pharmacological 
interventions available for ADHD symptoms, but no biological based treatments for the core 
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symptoms of ASD. Comorbidities are common, both with other NDDs and with psychiatric 
as well as somatic conditions. 
Strong genetic influences have been demonstrated for both disorders, with environmental 
factors potentially acting as triggers (ASD), or directing the course of the disorder over the 
life span (ADHD). Both phenotypes are continuously distributed in the population, with 
clinical phenotypes being the extremes. Twin studies have showed partly distinguishable 
genetic causes for different symptom domains, but also common pathways for different areas 
of symptoms within the disorders. The overlap between ASD and ADHD is substantial, 
phenotypically as well as etiologically, with partly shared genetic as well as environmental 
risk factors.  
The literature favors multifactor causal models, inclusive of different etiological pathways 
leading to the phenotypes. Evidence points to an interplay between genetic and 
environmental factors affecting development of the CNS and the immune system.150,151 The 
timing of events is considered decisive with certain critical time windows associated with 
increased or decreased susceptibility.3,150 It is suggested that the cumulative degree of risk 
factors is correlated to the severity of traits.152 
In ASD, the literature show a neuronal-cortical organization that impacts the developmental 
trajectories of social cognition (theory of mind),167 executive functioning,168 and top-down vs 
bottom-up processing (attention to detail/central coherence).169 In ADHD, the more 
consistent findings from brain imaging studies point at neuronal alterations affecting the 
frontal-subcortical-cerebellar pathways that control attention, inhibition, salience to rewards 
and motor control.111 Neurochemical findings in ADHD involve hypo functioning of 
catecholaminergic circuits (involved in dopamine release), particularly those projecting to the 
prefrontal cortex.170 
The study of discordant twin pairs (dimensionally and categorically) for ASD and ADHD 
gives high control of genetic and shared environmental factors and is therefore powerful in 
identifying NSE-driven behavioral and biological markers. The results from these designs in 
determining the risk or causes of ASD and ADHD are promising, however studies to date are 
limited in sample size, scope and generalizability.  
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2 AIMS AND RATIONALE 
The overall aim of this thesis is to identify new leads for ASD and ADHD etiology by the 
examination of discordant twin pairs. More specifically, the studies focus on identifying 
NSE-driven behavioral markers and environmental risk factors, through twin-difference 
designs.  
The objective of study I is to give an introduction and overview of the Roots of Autism and 
ADHD Twin Study in Sweden (RATSS), which is the framework for the other studies. In this 
protocol paper we describe the background, motivation, rationale and future perspectives of 
the RATSS.  
In study II, the objective is to investigate the phenotypical association between IQ and 
autism, both categorically and dimensionally, and the effect of genes and environment on the 
associations. For this purpose, a combined cohort of Swedish and Californian twins is 
examined, stratified on zygosity.  
In study III, the aim is to explore the associations between early medical history events and 
autism (categorical as well as dimensional), and to test the hypothesis of a cumulative effect 
of NSE factors on ASD risk. In this study, an explorative approach is taken examining a 
smaller sample of qualitatively discordant pairs for ASD. Next, the hypotheses generated 
from the first step of analysis are tested in a larger sample of quantitatively discordant ASD 
pairs, stratified on zygosity. 
In study IV, the aim is to investigate the association between a prenatal and early life excess 
or deficiency of metals, autistic traits and ASD. For this, a novel method is applied using 
tooth-matrix biomarkers to establish fetal and postnatal profiles in deciduous teeth. ASD 
qualitatively discordant and control pairs are included. 
In study V, the aims are to examine executive functioning as a behavioral marker in 
dimensionally-defined ADHD, and the effects of NSE. For this purpose, a sample of MZ twin 
pairs discordant for ADHD traits is examined.  
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3 METHODS 
3.1 DESIGN 
All studies included in this thesis are based on discordant twin pair designs (see above for a 
more detailed description of the rationale) and within-pair comparisons. The pairs are either 
qualitatively or quantitatively discordant. Qualitative discordancy is defined as a diagnosis of 
ASD or ADHD in the proband (i.e. the twin serving as starting point), and either no diagnosis 
or a different psychiatric diagnosis in the co-twin. Quantitative discordancy is defined by at 
least one-point intra-pair difference on dimensional ASD (i.e. SRS score or ADOS 
Comparison score) or ADHD scales (i.e. Child or Adult Behavior Checklist List; 
CBCL/ABCL).  
As a second step in study II and study III, the samples are stratified by zygosity. By 
comparing the within-pair regression coefficients between MZ and DZ pairs, an indication of 
the genetic and NSE contributions on the associations are given.171 In comparison to the 
ACE-modelling, the comparison of the magnitude of the associations in MZ and DZ pairs is 
crude. It gives an indication of genetic and NSE influences, but no estimation of the impact of 
the factors, nor any estimation of the shared environmental effects.172 See figure 1.  
In study IV, MZ and DZ pairs are not separated, and between-group comparisons are made 
between pairs discordant and concordant for ASD. In study V, the study sample is limited to 
MZ pairs.   
3.1.1 The Roots of Autism and ADHD Twin Study in Sweden 
The studies presented here are all based on a Swedish twin sample collected within the Roots 
of Autism and ADHD Twin Study in Sweden (RATSS) program, with the addition of a 
Californian sample in study II (see below for more details). The RATSS data collection 
started in August 2011 at the Center of Neurodevelopmental Disorders at Karolinska 
Institutet (KIND). Exclusion criteria for RATSS are indication of profound intellectual 
disability (IQ < 35), serious psychiatric (e.g., paranoid schizophrenia) or neurological (e.g. 
intractable epilepsy) conditions, or any well-defined genetic syndrome (e.g., fragile X). The 
subsamples are selected on qualitative and quantitative discordance for ASD or ADHD, 
zygosity, available samples (teeth) and time point for analysis, see table 1. 
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Figure 1. The figure shows different hypothetical intra-pair associations between exposure and outcome in 
MZ and DZ pairs. Since the MZ pairs share 100% of their genetic variation, the within-pair associations found in 
MZ pairs are adjusted for genetics and shared environmental factor, and the associations found must be driven 
by NSE factors. Since the environmental factors are assumed to be equal between MZ and DZ pairs, all 
differences between the zygosity groups must be due to genetic factors. Hence, (A) an equal intra-pair 
correlation in MZ and DZ pairs indicates an effect of NSE and no genetic effect on the association. (B) A 
stronger correlation in MZ than in DZ pairs, indicates both a NSE and a genetic effect. The genetic effect is in 
this case masking the NSE in the DZ pairs, resulting in a stronger association in MZ pairs when adjusting for 
genetics confounding. (C) An association in both groups, that is stronger in DZ pairs, indicates both a genetic 
and NSE effect, and the genetic effect being more dominant. (D) An association in the DZ pairs and no 
association in MZ pairs, indicates a genetic effect and no NSE effect. 
3.1.1.1 Procedure in RATSS 
The twins were identified and recruited via several sources. The main source was the 
Swedish Twin Registry (STR), either via studies based on the STR, such as i) the Child and 
Adolescent Twin Study in Sweden (CATSS) targeting all twins born in Sweden since 1994; 
with a response rate of approximately 80% and >25,000 twins born between 1994 and 
2004,173 or by combining STR with other registries, such as ii) the patient registry of the 
Swedish Board of Health and Welfare; iii) the clinical registries of the Division of Child and 
Adolescent Psychiatry, and iv) with the Habilitation and Health centers and pediatric units in 
Stockholm County. In addition, families were recruited via summons in the journals of the 
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National Society for neurodevelopmental disorders (Riksförbundet Attention), the National 
Society for Autism and Asperger syndrome (Autism och Aspergerföreningen), and the 
national twin organization (Tvillingklubben), exhibitions at their (bi-) annual meetings, and 
other forms of public media (e.g., reports on the project in newspapers and on television). 
The families were typically first contacted via mail and then via telephone. The majority of 
twins and their parents were either assessed at the Astrid Lindgren’s Children Hospital or at 
the KIND research clinic in Stockholm. A minority were assessed in their homes. 
Information, consents, and questionnaires were sent to the families for completion ahead of 
their visit. For families not living in the Stockholm area, travel and accommodation were 
arranged by the study nurse. The twins and the parents were all examined, tested and 
interviewed separately. Each family was assessed by three psychologists, or psychology 
students under supervision, trained on the different instruments. The order of tests was 
switched within and between the pairs. Total assessment duration was seven to eight hours 
including a longer lunch break and several shorter intervals. Best estimate psychiatric clinical 
consensus diagnoses based on all gathered information were made by the team of 
psychologists.   
Blood and saliva samples were collected at the clinic by a research nurse during the study 
visit. The teeth were naturally shed deciduous teeth that had been stored in the participants’ 
home. Teeth were brought to the study team in person by twins or parents and thereafter 
stored at room temperature at the clinic. 
3.1.2 The Californian Autism Twin Study 
The Californian twin sample was collected within the Californian Autism Twin Study 
(CATS) at Stanford University School of Medicine. The twins were born between year 1987 
and 2004, and the data was collected during 2005-2009. Inclusion and exclusion criteria 
were: “i) At least 1 child in the pair had a qualifying diagnosis (see later) in the Department 
of Developmental Services (DDS) electronic file or in client records; each twin in a pair who 
met this criterion was considered a proband.; ii) maternal residence in California at the time 
of delivery; iii) both co-twins were alive and residing in California at the time of enrollment; 
iv) no history among proband of neurogenetic conditions that might account for ASD (i.e., 
fragile X syndrome, Down syndrome, tuberous sclerosis, and neurofibromatosis); v) proband 
had a mental age more than 18 months; and vi) at least one parent with sufficient verbal and 
reading ability in English or Spanish was able to respond to interviews and checklists”.12, p 1096  
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3.1.2.1 Procedure in CATS 
Records from the DDS were used for identification of the Californian twin pairs. The DDS 
consists of 21 regional centers, coordinating services for persons with ASD, intellectual and 
other developmental disabilities. Patients are referred to the DDS centers from primary care 
providers, educators, public health clinics, other service agencies, and parents throughout 
California. For identification of twin births and to obtain demographic data, the electronic 
DDS client files were linked to Californian birth records. The parents were first contacted via 
a letter from the local DDS center, explaining the study and asking their consent to send 
identifying information to study staff at Stanford University. Next, they  research group at 
Stanford University would the contact them to further describe the study and obtain written 
consent. Families in northern California were assessed by a research team at Stanford 
University and families in southern California by a research team at the Autism Genetic 
Resource Exchange.12   
3.1.3 Sub-samples 
See table 1 for an overview of the samples included in the different studies. Study II consisted 
of a merged sample of 341 pairs, 132 pairs from the RATSS cohort and 209 pairs from the 
CATS cohort. The zygosity ratio was 127 MZ and 204 DZ pairs, ranging from ages 4 to 28 
years, with a mean age of 11.8 years. Thirty-six percent were females. Study III includes a 
total of 126 pairs. A two-step analysis was done. First, a subsample of 13 MZ pairs 
qualitatively discordant for ASD and 13 MZ typically developed (TD) control pairs was 
included for an in-depth exploration of medical records. Second, the findings from the first 
medical records review were confirmed in the remaining sample of 100 pairs, splitting the 
sample by zygosity groups (MZ pairs N=54; DZ pairs N=46). Study IV is based on tooth 
samples collected in 32 complete pairs (17 MZ and 15 DZ) and 12 individuals from twin 
pairs whose co-twin did not donate teeth. In this study, seven were complete pairs discordant 
for ASD diagnosis, six pairs concordant for ASD, and 19 pairs concordant non-ASD. In study 
V, a subsample of 27 MZ pairs quantitatively discordant for ADHD traits was selected.  
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Table 1. Description of samples and variables included in study II-V. 
 Study II Study III,  
Step 1 
Study III,  
Step 2 
Study IV Study V 
Research 
questions 
The association 
between ASD 
and IQ 
Explorative 
identification of 
medical factors 
contributing to 
ASD risk 
The effect of a 
cumulative load 
and specific 
medical factors 
on ASD risk 
The effect of 
metal regulation 
during pre- and 
postnatal 
development on 
ASD risk  
The role of NSE 
on executive 
functioning in 
ADHD 
Total N 
  
341 pairs 26 pairs 100 pairs 32 pairs + 12 
singletons 
27 pairs 
Sex (M:F) 218:123 32:20 109:91 46:30 40:14 
Zygosity  137 MZ pairs 
204 DZ pairs 
26 MZ pairs 54 MZ pairs 
46 DZ pairs 
17 MZ pairs 
15 DZ pairs 
27 MZ pairs 
Concordance 
(N pairs) 
70 conc. ASD,  
173 disc. ASD,  
90 conc. non-
ASD 
13 disc. ASD, 
13 conc. TD  
All quantitative 
disc. ASD traits 
7 disc. ASD,  
6 conc. ASD,  
19 conc. non-ASD 
All quantitative 
disc. ADHD traits 
Exposure 
measures / 
Independent 
variables 
• IQ • Intra-pair 
differences in 
medical records 
data of early 
medical events  
• Total load of 
medical events  
• Dysregulation 
• Birth weight 
• Exposure of ten 
different metals 
during pre- and 
postnatal 
development 
• CBCL/ABCL 
score  
• ADHD 
diagnosis  
Outcome 
measures / 
Dependent 
variables 
• ASD 
diagnoses  
• SRS scores 
• ASD diagnosis • SRS score • ASD diagnosis,  
• SRS score 
• ADOS 
Comparison score 
• The Tower test 
score 
• WCST score 
Covariates • Sex 
• Age 
• Site  
The groups were 
matched on:  
• Sex 
• Age 
• Sex 
• IQ 
• ADHD 
diagnoses  
• Zygosity 
• Sex 
• Gestational age 
• Birth weight  
• Age 
• IQ 
• Sex 
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3.2 MEASURES  
3.2.1 Zygosity 
In the RATSS cohort, zygosity was determined by genotyping of saliva or whole-blood 
derived DNA using Infinium Human-CoreExome chip (Illumina). The estimating identity 
by descent is analyzed using the PLINK software174 after quality control and removal of 
SNPs with a minor allele frequency less than 0.05 within the samples. All pairs of DNA 
samples showing ≥0.99 were considered as MZ pairs. For a minority of twins without 
DNA samples, an algorithm based on five questions on twin similarity derived from 571 
pairs of twins with known zygosity from the CATSS sample was used. Only twins with 
more than 95% probability of being correctly classified were assigned a zygosity by this 
method.173 In the CATS cohort, “zygosity of sex-concordant twin pairs was determined in 
batches of 10-20 pairs concomitantly. Nine short tandem repeat loci and the X/Y 
amelogenin locus were amplified. Twin pairs discordant for at least one marker were 
considered DZ. Twin pairs concordant on all markers were considered MZ”.12, p 1096 
3.2.2 Behavioral Measures 
All twins from the RATSS sample were assessed with an extensive behavioral protocol, 
including observations, neuropsychological tests, and self- and parent reports supported by 
data from medical records. Clinical consensus diagnosis (or lack of diagnosis) were supported 
by results from medical history, the Autism Diagnostic Interview – Revised (ADI-R),66 the 
Autism Diagnostic Observation Schedule Second Edition (ADOS-2),175 the Kiddie Schedule 
for Affective Disorders and Schizophrenia (K-SADS)73 or the Structural Clinical Interview 
for DSM-IV-TR Axis I (SCID)176 combined with the Diagnostic Interview for ADHD in 
adults (DIVA).74 Either the Wechsler Intelligence Scales for Children or Adults Fourth 
Editions (WISC-IV/WAIS-IV), the Leiter-revised (Leiter-r) scales in combination with the 
Peabody Picture Vocabulary Test Third Edition (PPVT-3) (in cases of low verbal abilities), 
and the parent rated Adaptive Behavior Assessment Scale 2nd Edition (ABAS-II)177 were 
collected for assessment of intellectual abilities and adaptive functions. 
Autistic traits were measured by parent reported Social Responsiveness Scale (SRS).75 The 
SRS has good to excellent psychometric properties for test-retest reliability (0.80-0.97), as 
well as interrater reliability (0.75-0.95), and satisfactory convergent validity (0.35-0.58).178,179 
ADHD traits were measured with the Attention problems (AP) scale from the parent-reported 
Child or (CBCL/6-18) or the Adult Behavior Check-List (ABCL/18-59), and by the self-rated 
AP scale from Youth Self Report (YSR/11-18) or Adult Self Report (ASR/18-59).180,181 
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Executive functioning was measured by two neuropsychological tests, a computerized 
version of the Wisconsin Card Sorting Test (WCST)182 and the Tower test from the broader 
Delis-Kaplan Executive Function System (D-KEFS).183 Both tests primarily measure 
planning skills. In addition the WCST measures cognitive flexibility and set shifting, while 
the Tower test also requires rule learning and inhibition skills. 
The CATS protocol included the same ASD measures: the ADOS, the ADI-R, and the SRS. 
The 5th edition of the Stanford-Binet 5th (SB-5) scale was collected for assessment of 
intellectual abilities.184 A study on the convergent validity between SB-5 and the WISC-IV in 
an ASD sample found a high correlation between corresponding intelligence scores (r=0.78-
0.88), though some differences were found, indicating a tendency for individuals to score 
higher on SB-5 than on WISC-IV.185  
3.2.3 Medical History  
For the medical history, an index of medical risk factors was created by an in-depth review of 
all factors loading on ASD cases in MZ pairs qualitatively discordant for ASD. Detailed 
information on medical and developmental history, with a focus on the first five years of life, 
was collected from questionnaires and medical records data. Intra-pair differences for the 
appearance, frequency and age of onset for developmental alterations, medical complications 
and life events were registered. All medical history events identified as differentiating within 
ASD discordant pairs (summing up to 31 factors), were added up to generate a total load for 
each individual. Adjustment for missing data was done according the formula below. 
Cumulative load =
Σ medical history events 
31 − NA
 
The index was evaluated by calculation of intraclass correlations coefficients (ICC) between 
the index data and the medical records/questionnaire data. The agreement ranged from 
moderate for cumulative load of early medical events (ICC=.55, 95% CI:.22-.75), substantial 
for dysregulation (ICC=.76, 95% CI:.58-.86), and almost perfect for birth weight (ICC=.93, 
95% CI:.88-.96). 
3.2.4 Tooth-matrix Methods  
In study IV, a novel tooth-matrix biomarker is used to measure multiple elements at a fine 
temporal resolution during early development (from 20 weeks before birth to 30 weeks after 
birth). Correlations between ASD measures and 10 different metals (i.e. Barium, Chromium, 
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Copper, Lithium, Magnesium, Manganese, Lead, Tin, Strontium, and Zinc) were tested for 
different time points during pre- and postnatal development.  
The teeth were analyzed using laser ablation-inductively coupled plasma mass spectrometry 
(LA-ICP-MS) and assigning developmental times.186,187 Herein, teeth are sectioned and the 
neonatal line (a line in enamel and dentine formed at the time of birth), as well as stepwise 
markings, were used to assign chronological information to sampling points. The laser 
ablation unit used was a New Wave Research (NWR) 193 system (ESI, USA) equipped with 
an ArF excimer laser. Helium was used as the carrier gas and mixed with argon after the 
ablation cell via a Y-piece. To increase sensitivity, the system was tuned daily using National 
Institute of Standards and Technology (NIST) standard reference materials (SRM) 612.  
3.3 STATISTICS  
3.3.1 Paired-data Analysis  
The first step of the analyses in study III, and the main analysis in Study V, are based on tests 
for paired-data. Due to the small sample sizes, non-parametric Wilcoxon signed rank test for 
continuous variables and McNemar’s test for dichotomous variables were used. In study III, 
an exploratory approach was taken, using two-tailed tests, while in study V, a direction of the 
relationship was hypothesized, and one-tailed tests performed.  
3.3.2 Generalized Estimating Equation Analysis 
In study II and III, conditional linear regression models, based on generalized estimating 
equations (GEE) analysis, were fitted. Each twin pair was entered as a separate stratum in the 
model. Since the conditional model quantify the association between the variables on within 
twin pair level, it adjust for all factors that are shared within the pairs (e.g., all genetic and 
shared environmental factors in MZ pairs), in turn allowing for adjustments of covariates not 
shared between the twins. In comparison to standard methods for repeated measures based on 
ordinary least squares, GEE modelling allows dependence between the variables and are here 
used for continuous, ordinal, and dichotomous variables.188,189        
3.3.3 Distributed Lag Non-linear Models 
Distributed lag models (DLMs) are used to model exposure-response relationships with 
delayed time effects. A non-linear DLM is a framework that can model non-linear exposure-
response dependencies and time-delayed effects simultaneously. It is based on a methodology 
that is using a bi-dimensional space of functions, describing the shape of a relationship based 
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on the space of the predictor as well as the lag dimension of its occurrence.190 In the tooth 
analysis in study IV, a DLM was fitted to detailed chronological data generated by tooth-
matrix biomarkers to detect critical developmental windows for the selected metals. This 
method allowed estimation of the effect of exposure at a specific time window, while 
adjusting for exposures at other times.  
3.3.4 Difference-in-difference Analysis 
In study IV, three steps of analyses were performed. The primary analysis determined 
developmental periods when there were disparities in elemental concentrations associated 
with ASD in twin pairs discordant for ASD and control twin pairs. The parameter estimate in 
this analysis was the smoothed mean differences in log concentrations of discordant pairs 
minus mean differences in control pairs:  
(Xcase – Xcontrol) – (Xcontrol-1 – Xcontrol-2) 
Thus, for example, when ASD cases from the discordant pairs have higher concentrations 
than their non-ASD co-twins, and these differences exceed the differences observed in 
control twin pairs, the association is positive. In a sensitivity analysis, we similarly compared 
ASD-discordant pairs with ASD-concordant pairs. Finally, correlations between element 
concentrations and ASD scores were calculated, using data from all participants. 
3.4 ETHICAL CONSIDERATIONS 
Collection of the RATSS cohort was approved by the Swedish national ethical board (diary 
no Ö 32-2010). The collection of the CATS cohort was approved by the California Health and 
Welfare Agency Committee for the Protection of Human Subjects and by the institutional 
review board at Stanford University (protocol id 13820).  
There are several ethical issues to consider in clinical studies like these. Most of the 
participants were children and adolescents (aged <18 years) and the majority had 
neurodevelopmental impairments, typically paired with low intellectual abilities, making it 
challenging for some participants to fully understand all possible risks and benefits 
implicated with their participation. The research teams made great efforts to explain all parts 
of the study in an adequate way adapted to the intellectual level of each individual (e.g., via 
images and sound recordings). No assessments or examinations were done if there were any 
signs of hesitation from the participant to take part, still, the motivation for young and low-
functioning participants could be questioned. On the other hand, the scientific and clinical 
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value of these group (low-functioning children with NDD) is particularly high as they are 
typically excluded from clinical studies.  
Participating in a study including multilevel assessments (cognitive assessments, genetic 
testing, biosampling, etc.), as in the RATSS project, could potentially raise awareness and 
worries about abnormalities that would not have been raised otherwise, affecting the well-
being of the twins and parents. Then again, study participation included a thorough 
neuropsychiatric, neurological and genetic assessment. In several cases, the participation in 
the study led to the notion of impairments not previously addressed. In these cases, the 
families were informed and referred for further examinations and interventions. In several 
cases, these were assessments that the families for long had asked for, but had not been 
provided with in the regular health care services. From the author’s clinical impression, from 
meeting and discussing with most of the participating families, the psychological and 
practical benefits reported by the families far exceeded the draw-backs they might have 
experienced related to participation.   
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4 RESULTS 
4.1 STUDY 1   
This paper supports cross-disciplinary multilevel twin studies as a powerful and unique tool 
to explore NDD etiology. The overall objective with the RATSS project is to generate a 
launch pad for novel surveys to understand the complex interplay between genes, 
environment and phenotypes. The project is mainly targeting MZ twin pairs discordant for 
categorical and dimensional ASD and ADHD. To increase the specificity of the results, 
control groups of DZ pairs, ASD and ADHD concordant pairs, and TD pairs are included. 
The multilevel data collection includes comprehensive behavioral phenotyping with 
assessments of psychopathology, neurocognitive profiles, heritability, medical history and 
anamnestic information. Within the study, the twins are physically and dysmorphologically 
assessed, and structural, functional and molecular brain imaging data is collected. Specimens 
are collected for induced pluripotent stem (iPS) cells, (epi)genetic, gut bacteria, protein-
/monoamine, and metal analyses. Experts from several research groups, within and outside 
Sweden, are involved in the project. To the author’s best knowledge, the RATSS is the 
largest multilevel clinical study of ASD and ADHD using MZ twin pairs.  
4.2 STUDY 2 
4.2.1 Preliminary Analyses (not published) 
Initially, we planned to do ACE-modelling on the combined Californian and Swedish cohort. 
In preparation for this, we first explored the two main variables of interest (IQ and autism), 
and the two samples separately. First, probandwise concordance rates were calculated for the 
categorical variables; ASD diagnoses and ID (here defined as IQ<70), stratified on zygosity 
(see table 2). Next, we explored the continuous variables and the relationship between them, 
by calculations of cross-pair correlations for SRS and IQ scores (ICC within pairs) and cross-
trait correlations for SRS and IQ scores (ICC between SRS score in twin 1 and IQ score in 
twin 2). The results revealed substantial differences between the samples, in particular for ID 
diagnoses and SRS scores, indicating that the combined sample was not appropriate for ACE 
modelling. The differences between the samples might be due to differences in recruitment, 
age, and severity. In particular the RATSS sample is not randomly selected, but rather 
selected on discordancy, which would bias the results in ACE-modelling. Therefore, we 
decided on an alternative statistical model that would not be biased by differences between 
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the cohorts, nor a non-randomized selection: conditional regression models. By fitting a GEE 
model, we were controlling for all factors shared within pairs, including differences between 
the cohorts (both twins in a pair were always from the same cohort).  
 
Table 2. Initial analyses of familiarity for ASD (categorical ASD and continuous SRS total score) and IQ 
(categorical ID and continuous IQ full scale score), stratified on zygosity and site. 
  
Calculations Californian sample Swedish sample 
Probandwise concordance for ASD  MZ: 63.7% 
DZ: 21.9% 
MZ: 48.0% 
DZ: 12.5% 
Probandwise concordance for ID  MZ: 60.4% 
DZ: 58.8% 
MZ: 87.5% 
DZ: 57.1% 
Cross-pair ICC for SRS  MZ: 0.13 
DZ: -0.32 
MZ: 0.62 
DZ: 0.27 
Cross-pair ICC for IQ MZ: 0.37 
DZ: -0.03 
MZ: 0.78 
DZ: 0.47 
Cross-trait ICC for SRS and IQ MZ: -0.44 
DZ: 0.27 
MZ: -0.47 
DZ: -0.13 
 
4.2.2 Final Results  
The descriptive analyses showed that the ASD twins in discordant pairs scored similarly high 
for autistic traits (SRS total score; z=-1.34, p>.05) and low IQ scores (full scale IQ; z=-0.86, 
p>.05), as the ASD twins in concordant pairs. Correspondingly, the non-ASD twins in 
discordant pairs showed similarly high IQ scores (z=-0.91, p>.05), as the non-ASD 
concordant twin. Although both non-ASD groups scored low for autistic traits, the non-ASD 
twins in discordant pairs presented significantly lower on autistic traits than the concordant 
non-ASD twins (z=-5.18, p<.001).  
Across all individuals, there was a significant negative association between IQ and ASD 
diagnoses (OR=0.92, 95% CI: 0.91-0.94) as for IQ and autistic traits (β=-0.55, 95% CI:-
0.60,-0.47, corresponding to a correlation of r=-0.57). Adjustment for sex, site, and age did 
not alter the significances of neither association. 
We then proceeded to examine if the associations remained at within-twin level, and thereby 
adjusting for all variables shared within pairs. There was a negative association between IQ 
and categorical ASD (OR=0.87, 95% CI: 0.83-0.91) also on within pair level, as for IQ and 
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autistic traits (β=-0.83, 95% CI: -0.91,-0.75). Next we tested the effect of zygosity, sex, site, 
and age on the association between IQ and autistic traits. The association was significant for 
both DZ (β=-0.87, 95% CI:-0.96,-0.78) and MZ twin pairs (β=-0.65, 95% CI:-0.81,-0.48), but 
significantly stronger in the DZ pairs (χ2 =5.47, p=.019). The IQ-autistic trait association was 
significant for both female (β=-0.93, 95% CI:-1.13,-0.73) and male (β=-0.71, 95% CI:-0.83,-
0.56) same-sex pairs, with no significant difference between the groups (p>0.05). The 
association was true in both the Swedish (β=-0.59, 95% CI:-0.83,-0.35) and the Californian 
cohorts (β=-0.87, 95% CI:-0.95,-0.78), but significantly stronger in the Californian (χ2 =4.65, 
p=.031). The association was significant in all age groups (age 4-11; β=-0.93, 95% CI:-1.04,-
0.81, age 11-17; β=-0.75, 95% CI:-0.86,-0.63, age 18-28; β=-0.57, 95% CI:-0.96,-0.19), but 
stronger in younger pairs (χ2 =6.85, p=.033) (see Table 3). 
Table 3. Regression estimates for associations between IQ and autistic traits at within-pair level, and 
comparisons of estimates between groups.  
Samples 
Association between IQ and SRS score 
Between-groups 
comparisons 
β 95% CI p χ p 
Total (N=306) -0.83 -0.91, -0.75  <.001 - - 
Male SS  (N =154) -0.71 -0.83, -0.56 <.001 
3.4 .062 
Female SS (N =74) -0.93 -1.13, -0.73 <.001 
MZ (N=122) -0.65 -0.81, -0.48 <.001 
5.47 .019 
DZ (N=184) -0.87 -0.96, -0.78 <.001 
Californian cohort (N=176) -0.87 -0.95, -0.78 <.001 
4.65 .031 
Swedish cohort (N=130)  -0.59 -0.83, -0.35 <.001 
Age 4-10y (N=128) -0.93 -1.04, -0.81 <.001 
6.853 .033 Age 11-17y (N=146) -0.75 -0.86, -0.63 <.001 
Age 18-28y (N=32) -0.57 -0.96, -0.19 .003 
 
Last, we corroborated the association by testing the triad ASD symptom domains and verbal 
and non-verbal IQ, separately. There was a significant association between autist traits and 
both verbal IQ (β=-0.80, 95% CI:-0.87,-0.72) and non-verbal IQ (β=-0.82, 95% CI:-0.91,-
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0.74)). The association with IQ was significant for all ASD symptom domains: social 
reciprocity (β=-0.42, 95% CI:-0.46,-0.39) communication (β=-0.03, 95% CI:-0.04,-0.03), and 
repetitive behavior and interests (β=-0.12, 95% CI:-0.13,-0.11). 
4.3 STUDY 3 
 In study III, there was an association between ASD and the cumulative load of early medical 
events when controlling for IQ and ADHD comorbidity. This association was true for both 
clinical ASD (Z=-2.85, p=.004) and dimensional traits (β=78.18, p=.002), in MZ pairs. A 
single, early medical factor correlated with the extent of autistic traits was dysregulation (i.e., 
feeding, sleeping abnormalities, excessive crying and worriedness) during the first year of life 
(β=31.75, p=.03). The association for birth weight and ASD traits was not significant, but 
showed a similar trend (β=-.01, p=.05). The associations were only true in MZ pairs, when 
adjusting for genetic factors, and not in DZ pairs with a larger genetic variance. See table 4. 
Table 4. Conditional linear regression between SRS total score and cumulative load of medical events, 
dysregulation problems and birth weight, including IQ and ADHD diagnosis as covariates 
 
 
 
 
 
 
   
Variables 
MZ (n=54 pairs) DZ (n=46 pairs) 
β SE p β SE p 
Cumulative load  
IQ 
ADHD 
78.18 
-0.19 
3.30 
26.59 
0.25 
5.64 
.01 
.22 
.26 
-8.71 
-1.20 
39.18 
46.03 
0.29 
8.09 
.43 
<.001 
<.001 
Dysregulation 
IQ 
ADHD 
31.75 
-0.33 
2.78 
16.2 
0.24 
5.87 
.03 
.08 
.32 
11.85 
-1.14 
40.63 
20.60 
0.30 
8.22 
.28 
<.001 
<.001 
Birth weight 
IQ 
ADHD 
-0.01 
-0.39 
0.71 
0.01 
0.24 
5.05 
.05 
.05 
.44 
-0.01 
-1.19 
40.10 
0.01 
0.28 
7.90 
.30 
<.001 
<.001 
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4.4   STUDY 4 
In study IV, we found ASD cases to have higher lead levels over the third trimester and first 
three months postnatally, in comparison to non-ASD twins. Zinc levels were reduced in ASD 
cases prenatally, and manganese levels were consistently lower in ASD cases both pre- and 
postnatally. The manganese deficiency was highest seven months after birth.  
By fitting DLMs, different developmental periods when elemental levels varied within the 
discordant pairs were identified. The greatest difference of lead levels was observed eight 
weeks postnatally, when ASD cases had 1.7 times higher lead than their non-ASD co-twins. 
Cases showed manganese deficiency 17 weeks before birth to 30 weeks postnatally, reaching 
seven-fold lower levels six months postnatally. Cases had reduced zinc levels, being 28% 
lower than their co-twins eight weeks prenatally. Analyses of clinical ASD severity (ADOS-2 
comparison score) and autistic traits (SRS-2 total scores) showed that eight of ten metals 
examined were significantly associated with ASD. Manganese was inversely associated with 
autistic traits as defined by SRS-2 (strongest association at 30 weeks, r=-0.37) and ASD 
severity on ADOS-2 (strongest association at 2 weeks, r=-0.30). Higher lead levels between 
eight weeks before birth and up to approximately week 25 postnatally were significantly 
positively associated with these indices, but the association was weaker than that observed 
for manganese (maximum r with SRS-2=0.10 at 13 weeks postnatally, and maximum r with 
ADOS-2=0.18 at seven weeks postnatally). A weak inverse association of zinc with the 
SRS-2 was also observed in the third trimester (maximum r at 12 weeks before  
birth=-0.03) and a positive association with ADOS-2 before birth and postnatally 
(maximum r=0.07 at 30 weeks postnatally, 95% CI:0.04-0.1).  
4.5 STUDY 5   
In study V, results showed a positive correlation between the intra-pair variation in ADHD 
traits and sub-scores of the Tower test; Total rule violation (rs=.41, p=.017) and Rule-
violation-per-item-ratio (rs=.38, p=.03), both primarily measuring inhibition. There was no 
association between ADHD and the Tower test total score, nor between ADHD and WCST 
scores (p>.05). Adjusting for age, IQ, and sex did not alter the significance of the results. 
Finally, the analyses were executed excluding pairs exposed to twin-to-twin-transfusion 
syndrome and pairs in which at least one twin was currently medicated for ADHD. Neither 
exclusion altered the significance of the results. 
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5 DISCUSSION  
5.1 STUDY 1   
One major challenge in etiological research is to link different levels of data, to not only 
identify single risk factors, but to also reach a broader understanding of the interplay between 
factors and to identify causal pathways. Ideally, multilevel data collection of large samples of 
well characterized cases and controls, would facilitate such investigations. To focus on the 
most informative and exceptionally well matched case-control pairs, such as MZ twin pairs 
discordant for the phenotype of interest, is a powerful design for this purpose. The RATSS 
study design has several strengths, in particular, the access to nation-wide registry data 
enabling the recruitment of an exclusive sample of discordant twins, which is combined with 
a comprehensive phenotyping and multilevel data collection. There are several techniques 
applied by collaborators in RATSS that have not previously been used in ASD/ADHD 
discordant twin designs. These include tooth-matrix for exploration of pre- and postnatal 
exposure of metals, reprogramming of iPS cells, mass spectrometry-based proteomic 
techniques for CSF analysis, and multimodal brain connectome approaches. Taken together 
the cross-disciplinary expertise in the study team, the identification and recruitment of twin 
pairs via nation-wide registers, and the comprehensive and multi-level data collection, the 
RATSS program has potential of finding novel leads for pathogenic pathways and 
informative biomarkers in ASD and ADHD. 
5.2 STUDY 2   
This study examined the link between IQ and ASD, for categorical ASD diagnoses and 
autistic traits, in a sample of carefully phenotyped twins across two countries. Genetic and 
environmental underpinnings were explored. Our findings show that lower IQ, clinical 
diagnoses as well as autistic traits, is associated with an increase of the presence of clinical 
ASD and increased autistic traits. The IQ-autistic trait link for MZ twins was significant, 
indicating NSE effects; whereas the stronger associations in DZ compared to MZ pairs 
suggest an additional genetic effect on the association. The phenotypic correlation between 
IQ and autistic traits is robust and it was significant for both sexes, for different age groups, 
across both the Californian and Swedish cohorts, for verbal and non-verbal IQ, as well as for 
all domains of the ASD symptom triad.  
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Our results for ASD diagnoses and the phenotypical overlap with IQ, are in line with the 
previous literature showing a high overlap between the ASD and ID.4 However, the results 
for IQ and autistic traits are partly novel. Previous literature indicates no or modest 
correlations between IQ and autistic traits,56,57,178,179,191 whereas our findings show a robust 
association between autistic traits and full scale IQ. In comparison to previous studies, our 
results are based on in-person IQ testing with first choice clinical IQ measures, while 
aforementioned studies have relied on either clinical records data, or IQ estimates based on 
online, parent- or telephone administrated assessments.56,57,178,179,191 
The literature on the heritability of the genetic overlap between IQ and ASD is inconclusive. 
Twin studies based on the TEDS cohort are reporting modest genetic correlations,56,57 
whereas one small Japanese twin study is reporting a high genetic correlation.192 Our results 
add to the previous knowledge by showing a NSE component in the etiology of the IQ-ASD 
link. The literature show several NSE risk factors common for both ASD and ID, such as 
gestational age, birth weight and 5-min Apgar score.59,60 If the IQ-ASD association is 
underpinned by changeable or reversible NSE factors, these might be areas with large 
potential for proactive interventions. Hence, our findings emphasize the importance of further 
research on the NSE factors in relation to the IQ-ASD overlap.  
5.3 STUDY 3   
The results from study III show early dysregulation, and foremost, the cumulative load of 
early medical events to index children at risk of ASD. While the findings of a cumulative 
effect of somatic symptoms on ASD risk is novel and contradictory to previous results,134 
early dysregulation as precursor of behavioral problems is in line with the literature.193,194 A 
large population-based study including over 4000 infants reported that early regulatory 
problems predict behavioral problems (i.e., external, internal and attentional problems) later 
in life.193 Similarly, a Swedish clinical study found that regulatory issues were frequent in 
children later diagnosed with ASD.194 Our findings show the associations to be significant 
in MZ pairs (adjusting for all genetic effect), but not in DZ pairs (only partly adjusting for 
the genetics). This indicates genetic effects due to the differences between the groups (i.e. 
only the degree of relatedness is assumed to differ between MZ and DZ pairs) as well as 
NSE effects, since the association is significant in MZ where genetic and shared 
environmental factors are adjusted for. Hence, while earlier studies have been unable to 
differentiate genetic and environmental effects on these phenomena, our results advance the 
results as they demonstrate an environmental effect on the association between early 
regulation difficulties and ASD.  
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From a clinical perspective, these results highlight early dysregulation problems and low 
birth weight, and foremost, a combination of several early medical events, as red flags for 
children at risk for developing ASD. Although symptoms of ASD emerge as early as at 12 
months of age,63 and ASD can quite reliably be diagnosed between 24 and 36 months of 
age, many children are not diagnosed until around the age of eight years.24 This is 
unfortunate as early detection is a prerequisite for early intervention,195 which is associated 
with better outcomes.196 The screening tools available for ASD before the age of 24 months 
are limited in sensitivity and specificity, and do not include early medical features.196 
Including the total load of early medical events in screening might for subgroups of 
children facilitate earlier ASD diagnosis.  
5.4 STUDY 4  
In study IV, the findings indicate associations between ASD and pre- and postnatal 
dysregulation of lead, zinc and manganese. This supports the hypothesis that prenatal and 
early childhood disruption (excess or deficiency) of multiple metals during critical 
developmental windows is associated with ASD, suggesting a systemic elemental 
dysregulation pathway for ASD etiology. At least one previous study used teeth to analyse 
metal toxicants in relation to ASD, reporting no significant differences between ASD cases 
and controls for lead, zinc or manganese,77 making our findings novel. In this previous study 
grounded teeth were analysed, not facilitating any investigation of the timing of the exposure, 
which might explain the contradictory results. Our study supports the evidence of joint 
interaction of environmental exposures with genetic variations in the etiology of ASD. The 
results show that the brain’s capacity to regulate metals varies with developmental age, 
suggesting in utero fluctuations in expression of metal transporter genes. Overall, it is likely 
that alterations in metal regulation in ASD cases involve multiple disruptions within the 
complex networks that regulate elemental uptake and distribution. 
5.5 STUDY 5  
In study V, the findings indicate an association between ADHD and inhibitory control, when 
adjusting for genetic and shared environmental factors. Since the within-pair design 
automatically control for genetic and shared environmental factors, the results indicate NSE 
components in the etiology of the association. Further, the findings support inhibition to be a 
core deficit in ADHD,197 and confirm ADHD to be an extreme on a continuum. The results 
suggest that planning and inhibitory control in ADHD, might be areas with larger potential 
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for change in comparison to other areas of executive functioning with higher degree of 
genetic influence. Hence, systematically studies of environmental effects on different aspects 
of executive functions in ADHD might lead to improved development of treatment and 
habilitation programs in ADHD. 
5.6 LIMITATIONS 
There are some limitations that need to be addressed in relation to the studies included here. 
In study II, the study sample is a combined sample from two different cohorts, and partly 
different measurements and procedures. Although the same standardized instruments for 
assessment of ASD were used at both sites (i.e., ADOS, ADI-R, SRS), a risk of discrepancies 
in testing procedure cannot be out ruled and no inter-rater reliability measures across sites are 
available. Four different IQ measures were used (i.e. SB-5, Wechsler scales, Leiter-r and 
PPVT-3). Though, with few exceptions, both twins in a pair were tested with the same test, 
limiting the risk for potential measurement bias. The same applies to all other factors shared 
between twins, and that automatically were adjusted in the within-pair analyses. Also, since 
the results were constant over two independent samples, with partly different measures, it 
confirms the robustness of the results.  
In study III the primary exposure variables (the cumulative load of early medical events, 
dysregulation and birth weight) are not primary risk factors for ASD, but secondary (or 
tertiary), although they precede an ASD diagnosis. Hence, in this study, we are unable to 
draw firm conclusions about the possible primary factors. Further, this study is unable to 
weight the different factors summing up to the cumulative load, making the estimations 
crude.  
For study III-IV, one might consider the sample sizes to be small with a noteworthy risk of 
type II errors, due to low statistical power. However, the significances reported still indicate 
strong and robust findings, although the non-findings have to be interpreted with caution.  
Further, MZ pairs discordant for highly heritable conditions such ASD and ADHD are rare, 
and our ASD and ADHD discordant sample actually represents a rather large minority of 
those discordant pairs in Sweden.198 
In study V, analyses of categorical clinical diagnoses were lacking power due to the small 
sample size, hence it would be of interest to confirm the results in a larger sample of pairs 
qualitatively discordant for ADHD. The outcome measure (executive functioning) is based on 
two neuropsychological tests primarily measuring planning skills. However, since inhibition 
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turned out to be the outcome variable significantly associated with ADHD, further studies 
with a twin design and more comprehensive measures of ADHD, inhibitory control and other 
executive functioning measures, would be valuable for confirmation of the results.  
In these studies we are stressing the significance of NSE as a function of differences in MZ 
pairs. Even if rare, it has to be noted that the differences between the MZ twins could also be 
due to post-twining de novo mutations and measurement errors.  
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6 CONCLUSION AND FUTURE DIRECTIONS 
This thesis is exploring different aspects of NDD etiology, in particular focusing on NSE 
factors in ASD. The studies are based on discordant twin pair designs and within-twin pair 
analyses, allowing for adjustment of genetic and shared environmental factors, with the aim 
of identifying NSE driven associations and markers.114 
Our ASD results are in favour of a multiple pathway model for ASD etiology. This implies 
ASD to be underpinned by a genetic predisposition with triggering pre- and postnatal NSE 
factors such as systemic elemental dysregulation (e.g., elevated lead-, and diminished zinc 
and manganese levels), and a total load of early medical events and/or manifestations (e.g., 
decreased intra-uterine growth, behavioral dysregulation). These factors might affect the 
developing brain if occurring during critical developmental time windows, resulting in ASD 
deficits and related phenotypes such as low IQ. See figure 2.  
In agreement with heritability studies suggesting NSE and genetic components in the etiology 
of ASD and ADHD,10 our results support NSE factors to underpin behavioral as well as 
biological markers in both ASD and ADHD. We show an association between early medical 
events and ASD, driven by NSE factors. In addition to genetic underpinnings, we show a 
NSE influence on the IQ-ASD link as well as on the link between executive functions and 
ADHD. If the identified phenotypical correlations are owing to changeable or reversible 
NSE factors, these might be areas with larger potential for change in comparison to other 
areas of behavioral functioning with higher degree of genetic influence. Hence, our results 
emphasize the importance of further exploration of environmental factors or areas of factors, 
involved in NDD etiology.  
The ASD findings (study II-IV) support the notion that ASD is continuously distributed in the 
population, with overlapping etiology between traits in the normal population and clinical 
phenotypes,10,14 as well as partly different etiology between different symptom domains.121 
The latter is demonstrated in study II. The different symptom domains, as defined by ADI-R, 
are all negatively correlated with IQ, but with significant differences in the strengths of the 
associations. In line with the Research Domain Criteria (RDoC), proposed by the American 
National Institutes of Health (NIH),199 our results emphasize the relevance of focusing on 
phenotypical and neurobiological correlates rather than in diagnostic constructs in NDD 
research. Also in ASD there might be subgroups with related behavioral characteristics (e.g., 
level of intellectual abilities) and neurobiological correlates, similar to on-going ADHD 
research.18,19  
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Figure 2 (previous page). The figure demonstrates a multifactor threshold model for ASD etiology. It 
shows autistic traits as a continuum on the y-axis, and time on the x-axis, from early prenatal to peri- and 
postnatal development. The marked female and male ASD risk load demonstrates a hypothesized line of the total 
sum of risk factors having a cumulative effect on autistic phenotypes. The two different lines for female and 
male risk load, demonstrate that the threshold for females to present a clinical phenotype is higher than for 
males. The total load includes a gene and environment interaction of genetic, epigenetic and prenatal 
environmental risk factors, as well as peri- and potentially postnatal risk factors (etiology). These factors effect 
the development of the immune- and the central nervous system, leading to an abnormal prenatal development of 
the brain, and resulting in postnatal brain abnormalities (pathophysiology), resulting in autistic and other 
neurodevelopmental phenotypes, that might be expressed as early manifestations such as behavioral 
dysregulation. 
 
ASD and ADHD diagnosis without comorbid conditions are rare.200 Still, many clinical 
studies are aiming at specific results, either excluding cases with known comorbidity or 
overlooking the assessment of comorbidity. In the studies presented here, we aim at an 
exploration of the most common comorbid conditions, such as ADHD and intellectual 
disability in ASD.  
As we show in study II, there is robust association between IQ and ASD, both for categorical 
and dimensional measures. Being the most crucial factors for prediction of ASD outcomes, 
we conclude that IQ is a key factor to consider in behavioral assessments of ASD. Although 
important for clinical outcomes, the inclusion of IQ in etiological studies of ASD might be 
debated. Whether it is appropriate to adjust for IQ, depends on the nature of the effect 
(confounding or mediating).61,201 If there is a confounding effect, IQ is related to both the risk 
factor and to the phenotype and falsely obscure or accentuate the relationship between them 
(as it is hypothesized for medical risk factors and ASD). The adjustment of IQ is then 
providing an undistorted estimate of the association between for example medical risk factors 
and ASD. If instead IQ would have had a mediating effect, either direct or indirect, 
adjustment might falsely obscure a true association. Hence, our results emphasize the 
importance of including IQ assessments in ASD assessments, but also that adjustment of IQ 
should to be interpreted with caution.  
Identification of causal environmental risk factors or markers, are essential for the appropriate 
targeting and development of environmental interventions. In the studies included here, we 
show a prenatal metal toxicant uptake of zinc, lead and manganese, during specific prenatal 
developmental time windows, to be associated with ASD risk. The results support the 
hypothesis of an in utero systemic elemental dysregulation in ASD. Prenatal elemental 
dysregulation in ASD might act via epigenetic modification of genes coding for metal 
transporters. In particular zinc plays an important role in protein synthesis, cell replication, 
tissue growth and repair.135,202 In addition, the literature suggest zinc to have a role as a 
regulator of multiple other metal homeostasis pathways, from early in the transcriptional 
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process to the optimal functioning of metal transporters.31 Hence, factors such as placental 
insufficiency and epigenetic alterations of metal transporters may disrupt zinc homeostasis 
and result in an elemental dysregulation of several metals potentially increasing ASD risk.  
Furthermore, we show a cumulative effect of peri- and postnatal medical events on ASD risk, 
suggesting factors to act both in utero and postnatally. Via an explorative approach, we 
replicated previous findings of postnatal dysregulation (excessive crying, feeding and 
sleeping difficulties) during the first years of life to be associated with ASD risk.194 If these 
are early manifestations, such as feeding problems being early symptom of an abnormal gut 
microbiota,138,203 and sleeping and excessive crying are early symptoms of difficulties with 
transition and increased stress in infants with ASD,194 is still to be explored.  
There are two main strengths with the studies included here. A multifactor model for NDD 
implies many causal factors with small effects. Identification of risk factors with a minor 
effect, might either be done by the inclusion of large samples or by holding interfering factors 
constant. The discordant MZ twin pair design is a demonstration of the latter, making it 
possible to explore less salient NSE factors. If there are strong genetic components in the 
etiology, as for ASD and ADHD, the genetic variation in ordinary case-control studies might 
supress small environmental effects.201,204 Secondly, our studies are based on an extensive 
and in-depth behavioural phenotyping. This facilitates exploration of different subgroups and 
cognitive profiles within the diagnoses (e.g., medical records data, IQ, executive functioning, 
first choice autism assessments, full psychiatric screening), while adjusting for several co-
variates.  
Based on the literature and findings presented here, I find it motivated to follow up with the 
following lines of research:  
i) Collection of larger samples of NDD discordant twin pairs for multilevel 
analyses. Extensive phenotyping in combination with novel techniques in a highly 
informative sample, such as the RATSS cohort, will facilitate causal modelling of 
GxE interactions,205 multi-modal brain imaging (combining anatomical, diffusion, 
and functional neuroimaging methods),86 and in vivo modelling of neurons by 
stem cell methods using iPS cells.149 This might lead to identificaion of strong 
hypothesis for causal pathways and reliable biomarkers, potentially facilitating the 
development of effective behavioral and pharmacological interventions, and 
earlier and more valid diagnostics.  
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ii) Further exploration of the effects of genes and environement on the phenotypic 
correlations (i.e., inhibitory control in ADHD, IQ in ASD). For this, large samples 
of randomly selected twins would be needed for bivariate twin modelling for 
exploration of the etiology of the phenotypic overlaps. 
iii) Combining extensive phenotyping and machine learning techniques for 
identification of subgroups based on behavioral measures, neurocognitive profiles 
and neurobiological correlates, to identify informative subgroups and further 
corroborate the underlying causes of the heterogentity of the disorders.206 For this, 
large population-based samples, would be needed for accurate training of 
algorithms.  
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